Kaszaki J, Czóbel M, Szalay L, Nagy S, Boros M
Institute of Surgical Research, University of Szeged, Pécsi u. 4., 6701, Szeged, Hungary.
Inflamm Res. 2008 Aug;57(8):396-402. doi: 10.1007/s00011-007-7224-x.
Enhanced production of endothelin-1 (ET-1) and the activation of mast cells (MCs) have been implicated in granulocyte sequestration. We compared local consequences of transient increases in circulating ET-1 in three separate circulatory beds in pentobarbital-anesthetized Wistar rats.
We determined whether pretreatment with ET-A receptor antagonist ETR-P1/fl peptide and MC stabilizer sodium cromoglycate would influence histamine- and granulocyte responses induced by 1 nmol/kg ET-1 iv. Plasma and tissue histamine contents were monitored, myeloperoxidase (MPO) level was determined from heart, lung and intestinal biopsies.
The ET-1 infusion caused significant plasma histamine elevations, enhanced MPO activity in all organs, decreased tissue histamine content in the lung and small bowel by approx. 50% , while the histamine content of heart did not change. ETR-P1/fl significantly decreased ET-1-induced intestinal and heart MPO changes, and inhibited histamine depletion in the small intestine but not in lung and heart tissues. Sodium cromoglycate inhibited the ET-1-induced neutrophil accumulation in the heart and intestine and did not influence MPO activity in the lung.
ET-1 release participates in the process of histamine liberation and subsequent secondary granulocyte accumulation through tissue-specific activation of ET-A receptors. ET-1-induced direct effects are predominating in pulmonary neutrophil activation, while MC-associated secondary changes play important roles in intestinal granulocyte recruitment.
内皮素-1(ET-1)生成增加以及肥大细胞(MCs)激活与粒细胞隔离有关。我们比较了戊巴比妥麻醉的Wistar大鼠三个不同循环床中循环ET-1短暂增加的局部影响。
我们确定ET-A受体拮抗剂ETR-P1/fl肽和MC稳定剂色甘酸钠预处理是否会影响1 nmol/kg静脉注射ET-1诱导的组胺和粒细胞反应。监测血浆和组织组胺含量,从心脏、肺和肠道活检组织中测定髓过氧化物酶(MPO)水平。
ET-1输注导致血浆组胺显著升高,所有器官中MPO活性增强,肺和小肠组织组胺含量降低约50%,而心脏组胺含量未改变。ETR-P1/fl显著降低ET-1诱导的肠道和心脏MPO变化,并抑制小肠组胺消耗,但不影响肺和心脏组织。色甘酸钠抑制ET-1诱导的心脏和肠道中性粒细胞聚集,且不影响肺中MPO活性。
ET-1释放通过ET-A受体的组织特异性激活参与组胺释放和随后的继发性粒细胞聚集过程。ET-1诱导的直接作用在肺中性粒细胞激活中占主导地位,而MC相关的继发性变化在肠道粒细胞募集中起重要作用。